⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT May 22, 2026

Glimepirid 1A Pharma 3 mg - Tabletten (Tablette)

📷 Wikipedia: Glimepiride · Source
Glimepirid 1A Pharma 3 mg - Tabletten (Tablette)
📷 Wikipedia: Glimepiride · Source
Glimepiride 1A Pharma 3 mg tablets are subject to a parallel export ban.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 5 days ago.
📈 Timeline
4 days in total
May 23, 2026 May 27, 2026

What is this? Glimepirid is a medicine used to lower blood sugar in people with diabetes. It comes as 3 mg tablets.

What's happening? The 3 mg tablets are not available right now. They have been out of stock since May 2026.

Does this affect me? If you take this exact medicine, you may need to find another option. Ask your pharmacist or doctor.

What should I do? Talk to your pharmacist or doctor before changing your medicine. They can help you find a safe replacement.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
GLIMEPIRID
Agency-published detail

🚫 Parallel export ban active · ATC: A10BB12 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-05-22]

First published
May 22, 2026
Last refreshed by us
13 hours ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 1 month ago

Glimepirid Hexal 2 mg - Tabletten (Tablette)

Glimepirid Hexal 2 mg tablets are subject to a parallel export ban.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Glimepirid 1A Pharma 3 mg - Tabletten (Tablette). Glimepiride 1A Pharma 3 mg tablets are subject to a parallel export ban.
▸ When was this alert issued?
This alert was issued on May 22, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.